Periodic reassessment prevents overtreatment; if progress normalizes or plates close closure

https://telegra.ph/Human-Growth-Hormone-for-Adults-vs-Children-Key-Differences-04-05

Periodic reassessment prevents overtreatment; if improvement normalizes or plates close to closure, clinicians taper or stop therapies to steer clear of needless risk.